Navigation Links
IPC The Hospitalist Company, Inc. Provides Second Quarter 2008 Outlook
Date:6/17/2008

NORTH HOLLYWOOD, Calif., June 17 /PRNewswire-FirstCall/ -- IPC The Hospitalist Company, Inc. (Nasdaq: IPCM), a leading national hospitalist physician group practice, today announced that it continues to experience favorable trends in patient encounters and expects second quarter 2008 net revenues to be in the range of $57 million to $59 million and operating income to be in the range of $4.2 million to $4.6 million. Absent the impact of acquisitions, the Company typically experiences a pattern of seasonality with net revenue and practice contribution in the first and fourth quarters of the year higher than those in the second and third quarters. The Company expects this pattern to continue and believes it is primarily due to the following factors:

-- the number of physicians the Company has on staff during the quarter, which may fluctuate based upon the timing of hires caused by the end of the academic year for graduating resident physicians and the schedule of the Internal Medicine Board exams and terminations in our existing practices; and

-- fluctuations in patient encounters which are impacted by hospital census and physician productivity and often reflect seasonality due to the higher occurrence of such illnesses as flu and pneumonia in patient populations in the first quarter.

As previously disclosed, the Company continues to invest in its infrastructure and expects to incur approximately $0.5 million to $0.6 million in incremental recurring quarterly expenses over first quarter 2008, excluding the $0.3 million related to a non-recurring IPO management bonus. In general, the incremental expense comprises continued physician leadership functions, ongoing investment in billing functions and increased stock compens
'/>"/>

SOURCE IPC The Hospitalist Company, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Benefits of hospitalist care confirmed in new study
2. Hospitalist Physicians Help Shorten Patient Stays
3. IPC The Hospitalist Company, Inc. Prices Initial Public Offering
4. IPC The Hospitalist Company, Inc. to Present at the 2008 UBS Global Healthcare Services Conference
5. IPC The Hospitalist Company, Inc. Announces Closing of IPO and Exercise of Underwriters Over-Allotment Option
6. IPC The Hospitalist Company, Inc. to Report Fourth Quarter and Year-End 2007 Financial Results
7. IPC The Hospitalist Company Announces Board of Director Member Changes
8. IPC The Hospitalist Company Reports Fourth Quarter and Full Year 2007 Results
9. IPC The Hospitalist Company Sets 2008 Annual Meeting Date
10. IPC The Hospitalist Company Added to Russell 2000 Index
11. IPC The Hospitalist Company, Inc. to Report First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... on cholesterol treatment and cardiovascular risk assessment state that ... from atherosclerotic cardiovascular disease or of having a heart ... risk profile (based on age, smoking history, and cholesterol ... for when and how aggressively to treat high cholesterol ... Men,s Health , a peer-reviewed publication from Mary Ann ...
(Date:7/22/2014)... (LALCA 2014) will be held August 21 23, ... the leading cause of death not only in Latin ... previous conferences in Chile, Mexico, Argentina and Brazil, international ... in the treatment and prevention of lung cancer and ... With tobacco being the leading cause of morbi-mortality worldwide ...
(Date:7/22/2014)... The Beryl Institute announces its fifth annual ... Program. These offerings reinforce the Institute’s commitment to support ... and the need for rigorous research to understand and ... programs are intended to encourage and support research ... on the patient experience before, during and after care ...
(Date:7/22/2014)... Ticket Down is a reliable source for cheap Manchester ... MD. There has never been a better time in the ... success of the American national soccer team at the 2014 World ... that fans of the world’s sport will be able to feed ... Champions Cup. The tournament will kick off on July 24 and ...
(Date:7/22/2014)... New York, NY (PRWEB) July 22, 2014 ... Risperdal lawsuits ( http://www.risperdallawsuitcenter.com/ ) in ... his decision to deny punitive damages in cases ... (male breast growth), Bernstein Liebhard LLP reports. In ... New also denied a plaintiffs’ request to certify ...
Breaking Medicine News(10 mins):Health News:The Beryl Institute Opens Applications for 2014 Patient Experience Grant and Scholar Programs 2Health News:The Beryl Institute Opens Applications for 2014 Patient Experience Grant and Scholar Programs 3Health News:Manchester United vs. Inter Milan Tickets Fedex Field Landover: Ticket Down Slashes Ticket Prices for Inter Milan ManU International Champions Cup Match in Washington, DC 2Health News:Manchester United vs. Inter Milan Tickets Fedex Field Landover: Ticket Down Slashes Ticket Prices for Inter Milan ManU International Champions Cup Match in Washington, DC 3Health News:Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuit News: Pennsylvania Judge Won’t Reconsider Denial of Punitive Damages for Risperdal Gynecomastia Plaintiffs, Bernstein Liebhard LLP Reports 4
... taking the contraceptive pill may find themselves less responsive to ... The study, published in the journal Human Reproduction, measured the ... - while taking and not taking the Pill. ... experienced rises and falls in their ability to sense smells, ...
... vocal cords improves voice problems in Parkinson's disease. One of ... voice quality experienced by some patients. This problem is known ... abnormalities in the area of the voice box or larynx.// ... may be hard to understand what they are saying. You ...
... might explain common digestive symptoms like gas, pain and ... the link between fructose intolerance and the symptoms of ... abdominal discomfort, bloating and changes in bowel habit. Fructose ... honey. Some people can't digest it, but the condition ...
... past evidence that hormone replacement might lower stroke risk ... does not protect women from recurrent strokes and may ... evidence that hormone replacement therapy does not have the ... doctors have long thought hormone replacement therapy might help ...
... cheese and whole milk may be at increased risk ... The rates of two types of cancer--gastric cardia and ... 30 years. To investigate potential links between these and ... dietary factors, Dr. Susan T. Mayne from Yale University ...
... who undergo surgery for breast cancer will experience ... surgery, according to new research. Dr. Erica S. ... colleagues reported the findings at the American Public ... researchers asked 266 women who had undergone breast ...
Cached Medicine News:
(Date:7/22/2014)... 2014 Research and Markets has ... by Equipment, by Reagent, by Application - Global Forecast ... http://photos.prnewswire.com/prnh/20130307/600769 Biopharmaceuticals are ... one of the most important and widely used techniques ... segment of the cell culture market in 2013. Growth ...
(Date:7/22/2014)... 22, 2014  Decision Resources Group finds that the market ... will remain relatively stagnant at a value of around ... percutaneous coronary intervention (PCI) volumes are growing faster in ... as the United States and ... by the increase in penetration of PCI procedures relative to ...
(Date:7/22/2014)... , July 22, 2014 Legislation backed ... Access to Local Pharmacies Act of 2014") championing ... D would undermine the availability of lower cost ... $21 billion over the next 10 years, according ... by the Pharmaceutical Care Management Association (PCMA). ...
Breaking Medicine Technology:Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 2Global Cell Culture (Bioreactor, Incubator, Centrifuge) Market - Forecast to 2018 3The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 2The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 3New Study: H.R. 4577 to Cost $21 Billion over 10 Years 2New Study: H.R. 4577 to Cost $21 Billion over 10 Years 3
... Mylan Inc. (Nasdaq: MYL ) today ... final approval from the U.S. Food and Drug Administration ... Valacyclovir Hydrochloride Tablets, 500 mg (base) and 1000 mg ... for the herpes virus infection. The product is being ...
... National Anesthesia Services, Inc. celebrates its 21st anniversary as one of ... a locum tenens and permanent basis in hospitals, surgery centers and medical ... , , ... when we first began," said president and owner Stephen Read . ...
Cached Medicine Technology:Mylan Receives Approval for Generic Version of Valtrex® 2National Anesthesia Services, Inc. Celebrates 21 Years of Dynamic Growth and Achievement 2
... Mammography has been FDA approved, and represents ... It is the first and only mammography ... - the highest available. SenoScan's larger field ... breast support is more comfortable and helps ...
... The P3000 heralds a new concept in pupillometry, ... infrared optical system developed for the P2000. ... in which we have paid particular attention to ... Our new system is extremely flexible, allowing you ...
... the most useful features is the PupilFit ... mathematical analysis of the pupil images, producing ... instantaneously. The fitted circle is shown as ... proof that the measurement ismeaningful, and not ...
... An easy-to-operate, semi-automatic urine analyzer that ensures ... your lab efficiency by reducing "hands on" ... makes it an ideal fit for work ... Criterion II Analyzer is designed for continuous ...
Medicine Products: